
Mounjaro KwikPen 5 mg contains tirzepatide, a once-weekly injectable medicine used to improve blood sugar control in adults with type 2 diabetes. It works by activating GIP and GLP-1 receptors to enhance insulin release and reduce appetite.
| Manufacturer | Eli Lilly and Company |
| Generic Name | Tirzepatide |
| Strength | 5mg |
| Package size | 1 pre-filled 2.4 ml pen |
| Used for | Type 2 diabetes and weight control |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Saudi Arabia, Qatar, Kuwait, and many other countries. |

Authentic Medicines

Fast Delivery

Secure Payment

24/7 Support
| Package | USD | GBP | AUD | PHP | TND | KRW | RON | HKD | MYR | THB | SGD | AED | SAR | QAR | KWD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 pre-filled 2.4 ml pen | $340 | £252 | A$474 | ₱21,315 | د.ت989.74 | ₩455,294 | lei 1,539 | HK$2,666 | RM1,383 | ฿11,227 | S$431 | د.إ1,248.82 | ر.س1,276.70 | ر.ق1,237.94 | د.ك103.700 |
Tirzepatide activates both GIP and GLP-1 receptors, which regulate blood sugar and appetite. This leads to better insulin secretion, reduced hunger, and improved glucose control.